Try Alerts Free   |   Login
Technology › Semiconductors And Related Devices

SLAB Price Correlated With Financials For Silicon Laboratories

Free historical financial statements for Silicon Laboratories Inc. See how revenue, income, cash flow, and balance sheet financials have changed over 45 quarters since 2011. Compare with SLAB stock chart to see long term trends.

SLAB Stock Compared to Quarterly

SLAB Income Statement

Revenue, Net:233814000
Revenue Per Share:6.1525
Cost of Goods & Services Sold:78042000
Gross Profit:155772000
Selling, General & Admin Expense:44647000
Research & Development Expense:77542000
Total Operating Expenses:122189000
Operating Income:33583000
Income Taxes:11689000
Net Income:22907000
Earnings Per Share, Basic:0.6
Shares Outstanding, Basic Avg:38003000

SLAB Cash Flow

Operating Activities Net Income:
Change in Accounts Receiveable:-19080000
Net Cash from Operations:85209000
Net Cash from Operations Per Share:2.2422
Repurchases/Buybacks Common Stock:157778000
Net Cash from Financing Activities:-166533000
Property, Plant & Equipment Purchases:4554000
Net Cash from Investing Activities:-217388000
Net Change in Cash & Equivalents:-308712000

SLAB Balance Sheet

Cash and Cash Equivalents:765911000
Short-Term Investments:1167807000
Accounts Receivable, Net:79233000
Total Current Assets:2123398000
Property, Plant & Equipment, Net:147940000
Total Assets:2843762000
Accounts Payable:64388000
Total Short-Term Liabilities:246208000
Total Liabilities:836107000
2. Significant Accounting Policies Basis of Presentation and Principles of Consolidation The Company prepares financial statements on a 52- or 53-week fiscal year that ends on the Saturday closest to December 31. Fiscal 2021 had 52 weeks. Fiscal 2020 had 53 weeks with the extra week occurring in the first quarter of the year. Fiscal 2019 had 52 weeks. Fiscal 2021, 2020 and 2019 ended on January 1, 2022, January 2, 2021 and December 28, 2019, respectively. The accompanying Consolidated Financial Statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Foreign Currency Transactions The Company’s foreign subsidiaries are considered to be extensions of the U.S. Company. The functional currency of the foreign subsidiaries is the U.S. dollar. Accordingly, gains and losses resulting from remeasuring transactions denominated in currencies other than U.S. dollars are included in interest income and other, net in the Consolidated Statements of Income. Use of Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Among the significant estimates affecting the financial statements are those related to inventories, goodwill, acquired intangible assets, other long-lived assets, revenue recognition, stock-based compensation and income taxes. Actual results could differ from those estimates, and such differences could be material to the financial statements. Fair Value of Financial Instruments The fair values of the Company’s financial instruments are recorded using a hierarchical disclosure framework based upon the level of subjectivity of the inputs used in measuring assets and liabilities. The three levels are described below: Level 1 - Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date. Level 2 - Inputs other than Level 1 that are directly or indirectly observable, such as quoted prices for similar assets or liabilities and quoted prices in less active markets. Level 3 - Inputs are unobservable for the asset or liability and are developed based on the best information available in the circumstances, which might include the Company’s own data. 2. Significant Accounting Policies (Continued) Cash and Cash Equivalents Cash and cash equivalents consist of cash deposits, certificates of deposit, money market funds and investments in debt securities with original maturities of ninety days or less when purchased. Investments The Company’s investments typically have original maturities greater than ninety days as of the date of purchase and are classified as either available-for-sale or trading securities. Investments in available-for-sale securities are reported at fair value, with unrealized gains and losses, net of tax, recorded as a component of accumulated other comprehensive income (loss) in the Consolidated Balance Sheet. Investments in trading securities are reported at fair value, with both realized and unrealized gains and losses recorded in interest income and other, net in the Consolidated Statement of Income. Investments in which the Company has the ability and intent, if necessary, to liquidate in order to support its current operations (including those with contractual maturities greater than one year from the date of purchase) are classified as short-term. The Company reviews its available-for-sale investments as of the end of each reporting period for declines in fair value based on the specific identification method. The Company records an allowance for credit loss when a decline in fair value is due to credit-related factors. The Company considers various factors in determining whether an investment is impaired, including the severity of the impair

Data imported from Silicon Laboratories Inc SEC filings. Check original filings before making any investment decision.